HK Movers | Bao Pharma Jumps 105% in Grey Market

Bao Pharma shares jumped 105.3% in in Hong Kong grey market.

Founded in 2019, Bao Pharma focuses on four key therapeutic areas, including large-volume subcutaneous drug delivery systems, antibody-mediated autoimmune disease therapies, assisted reproduction and recombinant biologics.

The company recorded revenue of 41.99 million yuan ($5.94 million) in the first half of this year, up 27.2 times year-on-year from 1.49 million yuan in the same period last year. During the same period, its loss widened 9.4% year-on-year to 180 million yuan.